REQUEST A DEMO
Total
USD $0.00
Search more companies

Vertex Pharmaceuticals (Poland) Sp. z o.o. (Poland)

Main Activities: Pharmaceutical Preparation Manufacturing
Secondary Activities: Other Basic Inorganic Chemical Manufacturing | Other Basic Organic Chemical Manufacturing | Adhesive Manufacturing | Explosives Manufacturing | All Other Chemical Product and Preparation Manufacturing | Other Miscellaneous Nondurable Goods Merchant Wholesalers | Department Stores
Full name: Vertex Pharmaceuticals (Poland) Sp. z o.o. Profile Updated: November 08, 2025
Buy our report for this company USD 29.95 Most recent financial data: 2024 Available in: English & Polish Download a sample report

Vertex Pharmaceuticals (Poland) Sp. z o.o. is based in Poland, with the head office in Warsaw. It operates in the Pharmaceutical Preparation Manufacturing sector. It was first established on December 08, 2017. From the latest financial highlights, Vertex Pharmaceuticals (Poland) Sp. z o.o. reported a net sales revenue increase of 14.93% in 2024. Its total assets decreased by 4.21% over the same period. In, 2024, the company’s net profit margin increased by 2.37%.

Headquarters
Ul. Ludwika Warynskiego 3A
Warsaw; Mazowieckie; Postal Code: 00-645

Contact Details: Purchase the Vertex Pharmaceuticals (Poland) Sp. z o.o. report to view the information.

Basic Information
Registered Capital:
Purchase the Vertex Pharmaceuticals (Poland) Sp. z o.o. report to view the information.
Financial Auditors:
Purchase the Vertex Pharmaceuticals (Poland) Sp. z o.o. report to view the information.
Incorporation Date:
December 08, 2017
Key Executives
Purchase this report to view the information.
Management Board Member
Purchase this report to view the information.
Management Board Member
Purchase this report to view the information.
Management Board Member
Purchase this report to view the information.
Management Board Member
Purchase this report to view the information.
Proxy
Ownership Details
Purchase this report to view the information.
100%
Company Performance
Financial values in the chart are available after Vertex Pharmaceuticals (Poland) Sp. z o.o. report is purchased.
Looking for more than just a company report?

EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.

Request a demo of the EMIS service
Key Financial Highlights
Annual growth percentages for latest two years in local currency PLN. Absolute financial data is included in the purchased report.
Net sales revenue
14.93%
Total operating revenue
15.12%
Operating profit (EBIT)
18.35%
EBITDA
18.35%
Net Profit (Loss) for the Period
72.18%
Total assets
-4.21%
Total equity
55.69%
Operating Profit Margin (ROS)
0.21%
Net Profit Margin
2.37%
Return on Equity (ROE)
3.43%
Quick Ratio
0.6%
Cash Ratio
0.56%

To view more information, Request a demonstration of the EMIS service

Buy this company report
Need ongoing access to company, industry or country information?